Before Tuesday�� opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.
Morgan Stanley Upgrades BB&T to “Overweight”
BB&T Corporation (BBT) has been upgraded from “Equal Weight” to “Overweight” at Morgan Stanley. The firm has raised its rating on BBT due to a valuation call. Analysts currently have a $40 price target on BBT, suggesting a 16% increase from the stock’s current price of $34.29. BBT has a dividend yield of 2.68%.
5 Best Construction Material Stocks To Own For 2015: Hospira Inc (HSP)
Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.
Specialty Injectable Pharmaceuticals
Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.
Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.
Other Pharmaceuticals
Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.
Medication Management
Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.
Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.
The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.
Advisors' Opinion:- [By Sean Williams]
Drug developer Hospira (NYSE: HSP ) also had a notably impressive day, advancing 6% after receiving a positive opinion on inflectra in Europe. Designed to treat rheumatoid arthritis, inflammatory bowel disease, and plaque psoriasis, inflectra, a biosimilar of Johnson & Johnson's�Remicade, received a positive opinion from the Committee for Medicinal Products for Human Use, meaning it would recommend the European Medicines Agency to approve the drug. This could be a key win for Hospira, because J&J's Remicade was responsible for roughly $6 billion in annual revenue, and could be a huge bottom-line boost for Hospira.
- [By Saumya Vaishampayan]
Hospira Inc. (HSP) �shares gained 7%. The company on Wednesday posted a 58% surge in third-quarter profit as revenue edged up 1.4%, with adjusted profit and sales beating expectations.
- [By Dimitra DeFotis]
Walgreen (WAG) stock is down 2.4%, despite speculation today that hospital products company�Hospira�(HSP) could bid for Danone�� medical-nutrition unit in what would be the latest so-called inversion deal — and a big one at possibly $5.1 billion. �Already in the works:�AbbVie�(ABBV) and�Medtronic�(MDT) are pursuing deals with�smaller Irish rivals that will permit the companies to switch their home base to Ireland.
- [By Jonas Elmerraji]
Pharmaceutical firm Hospira (HSP) hasn't done much since July; shares have been trading sideways for months now. But even though Hospira hasn't really participated in the recent rally, there's still a trade to be made here.
Hospira is currently forming a rectangle pattern, a price setup that's formed by a horizontal resistance level above shares at $42 and another horizontal support level down at $38.50. The rectangle gets its name because it essentially "boxes in" shares. The high-probability trade comes when HSP exits its channel -- a move through $42 is a buy signal, whereas a drop below $38.50 is a signal to sell.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Rectangles, triangles, and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That $42 resistance level, for example, is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
Sit on the sidelines until HSP breaks outside of the rectangle.
Hot Stocks To Own Right Now: CBIZ Inc (CBZ)
CBIZ, Inc. (CBIZ) provides professional business services, products and solutions. These services are provided to businesses of various sizes, as well as individuals, governmental entities and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ delivers its services through four practice groups: Financial Services, Employee Services, and National Practices. Its Financial Services group includes accounting, tax, financial advisory, valuation, litigation support, internal audit, family office services, fraud detection and real estate advisory. Its Employee Services group provides group health, property and casualty, retirement planning, payroll services, life insurance, human capital management, compensation consulting, recruiting and actuarial services. MMP group includes coding and billing, accounts receivable management and full practice management services. National Practices group includes managed networking and hardware services, health care consulting, and mergers and acquisitions. Effective July 1, 2012, the Company acquired the assets of Stoltz and Company, LTD., L.L.P. In October 2012, it acquired the assets of ProMedical, Inc. On December 31, 2012, the Company acquired the non-attest assets of PHBV Partners, L.L.P. Effective May 1, 2013, it announced that it has acquired Associated Insurance Agents. In September 2013, CBIZ, Inc completed the sale of its Medical Management Professionals (MMP) business to Zotec Partners, LLC.
On January 1, 2011, CBIZ sold its individual wealth management business. Effective November 1, 2011, the Company acquired the defined benefit actuarial consulting practice of PSA Insurance and Financial Services of Hunt Valley, Maryland. During the year ended December 31, 2011, CBIZ acquired four businesses: Thompson Dunavant PLC, Gresham Smith LLC, Multiple Benefit Services, Inc. and Atlantic MDR, LLC (d/b/a Advantage Benefit Planning). On January 1, 2012, the Company acquired Meridian Insurance Group, LLC.
Financial! Services
The Financial Services practice is divided into a Financial Services division, representing the United States, and a National Services division consisting of those units that provide their services nationwide. CBIZ and its subsidiaries maintain joint-referral relationships and administrative service agreements (ASAs) with independent licensed Certified Public Accounting (CPA) firms under which audit and attest services may be provided to CBIZ�� clients by such CPA firms. Under these ASAs, CBIZ provides a range of services to the CPA firms, including (but not limited to) administrative functions, such as office management, bookkeeping, and accounting, preparing marketing and promotion materials, providing office space, computer equipment, and systems support, and leasing administrative and professional staff. As of December 31, 2011, CBIZ maintained ASAs with four CPA firms.
Employee Services
The business units that comprise CBIZ�� Employee Services group are organized between Retail and National Services. The Retail offices provide services within their geographic area. The National group includes a number of specialty operations that provide services on a national scale. CBIZ�� Employee Services group maintains relationships with different insurance carriers. Some of these carriers have compensation arrangements.
National Practices
The National Practices group offers technology, health care consulting, and merger and acquisition services. The units within the National Practices group each have a Business Unit President.
Advisors' Opinion:- [By Seth Jayson]
CBIZ (NYSE: CBZ ) reported earnings on July 29. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), CBIZ whiffed on revenues and missed estimates on earnings per share.
Hot Stocks To Own Right Now: Pendrell Corp (PCO)
Pendrell Corporation (Pendrell), formerly ICO Global Communications (Holdings) Limited, incorporated on March 17, 2000, is a fully-integrated intellectual property (IP) investment and advisory company. The Company develops and implements strategies to create, acquire, commercialize and license IP. The Company provides IP valuation services, analysis and strategic advice through Pendrell�� wholly owned subsidiary, Pendrell Technologies LLC (PTL) and its wholly owned subsidiary, Ovidian Group LLC (Ovidian Group). It also assists its clients with a rangeof IP services, including IP valuation and investment analysis, IP landscape analysis, IP divestitures and IP risk mitigation strategies. On June 17, 2011, the Company acquired Ovidian Group. On October 31, 2011, the Company�� subsidiary, Pendrell Technologies LLC, acquired 90.1% interest in ContentGuard Holdings, Inc. In November 2011, Technicolor SA sold its 25.7% interest in ContentGuard to Pendrell Technologies LLC, a wholly owned subsidiary of Pendrell Corporation. During the year ended December 31, 2011, the Company completed the divestiture of its satellite communications assets. Effective February 25, 2013, the Company acquired 68% interest in Provitro Biosciences LLC.
The Company competes with Acacia Research Corporation, Coller IP Management, Intellectual Ventures, Mosaid, Rovi, RPX, Wi-Lan, Boston Consulting Group, Bain & Company and Red Chalk Group.
Advisors' Opinion:- [By Roberto Pedone]
Pendrell (PCO) is a fully integrated intellectual property investment and advisory firm. This stock closed up 2.3% to $2.18 in Tuesday's trading session.
Tuesday's Range: $2.08-$2.22
52-Week Range: $1.04-$2.71
Tuesday's Volume: 263,000
Three-Month Average Volume: 457,962From a technical perspective, PCO bounced higher here back above its 50-day moving average of $2.16 with lighter-than-average volume. This move is quickly pushing shares of PCO within range of triggering a near-term breakout trade. That trade will hit if PCO manages to take out some near-term overhead resistance at $2.22 with high volume.
Traders should now look for long-biased trades in PCO as long as it's trending above Tuesday's low of $2.08 or above $2 and then once it sustains a move or close above $2.22 with volume that hits near or above 457,962 shares. If that breakout triggers soon, then PCO will set up to re-test or possibly take out its next major overhead resistance levels at $2.50 to its 52-week high at $2.71.
Hot Stocks To Own Right Now: Mine Safety Appliances Company (MSA)
Mine Safety Appliances Company develops, manufactures, and supplies health and safety products used by workers in the fire service, homeland security, construction, and other industries, as well as the military. It offers respiratory protection products, including self contained breathing apparatus, air-purifying respirators, gas masks, and escape hoods; and portable and permanent gas detection instruments, such as single-and multi-gas hand-held detectors, multi-point permanently installed gas detection systems, flame detectors, and open-path infrared gas detectors. The company also provides thermal imaging cameras; head, eye, face, and hearing protection products, such as industrial hard hats, fire helmets, and military helmets and communication systems; and body protection products comprising fall protection equipment and ballistic body armor. In addition, it offers consumer and contractor safety products through retail channels. The company?s products are used by first responders; general industry workers; military personnel; oil, gas, petrochemical, and chemical workers; hazmat and confined space workers; and construction workers and contractors. Mine Safety Appliances Company sells its products in North America, Europe, and internationally. The company was founded in 1914 and is based in Pittsburgh, Pennsylvania.
Advisors' Opinion:- [By Chuck Saletta]
The third biggest gainer for the IPIG portfolio last week was safety-equipment purveyor Mine Safety Appliances (NYSE: MSA ) , which also rose on its earnings news. Mine Safety Appliances' numbers were pretty strong, once you backed out the impact of currency fluctuations and a divestiture, and the market rewarded the company for those results. Solid results like that are also a decent reason for a company's stock to rise, but of course, what the company delivers in the future will drive where its stock goes next.
- [By Chuck Saletta]
Take Mine Safety Appliances (NYSE: MSA ) , for instance. The safety equipment provider missed expectations in its most recent quarter. But its very solid balance sheet helps protect it from the cyclicality in its industry, and its overall strength enabled it to increase its dividend last week, in spite of that short-term weakness. That solid balance sheet was one of the key factors that led to its selection for the iPIG portfolio and the reason the portfolio still has room for the company even though it slipped.
- [By Chuck Saletta]
Two of those companies, railroad tycoon CSX (NYSE: CSX ) and safety equipment provider Mine Safety Appliances (NYSE: MSA ) , paid out higher per-share amounts than they did last quarter. Both raised their payments by about 7% -- with CSX's moving from $0.14 to $0.15 per share and Mine Safety Appliances' rising from $0.28 to $0.30.
- [By Aaron Levitt]
For investors, American Railcar could be one best sleepy plays on the shale boom.
Mine Safety Appliances (MSA)No industry likes seeing more regulations — except for those firms that help energy companies comply with those new rules. In the oil and gas industry that would be Mine Safety Appliances (MSA).
Hot Stocks To Own Right Now: CRA InternationalInc.(CRAI)
CRA International, Inc. provides litigation, regulatory, financial consulting, and management consulting services worldwide. It advices clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guides corporations through critical business strategy and performance-related issues. The company offers consulting services, including research and analysis, expert testimony, and support in litigation and regulatory proceedings in various areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. It also provides consulting services related to class certification, damages analysis, expert reports and testimony, regulatory analysis, strategy development, valuation of tangible and intangible assets, risk management, and transaction support to law firms, businesses, and government agencies. In addition, the company offers management consulting services consisting of strat egy development, performance improvement, corporate portfolio analysis, market demand estimation, new product pricing strategies, intellectual property and other assets valuation, competitors? actions assessment, and new sources of supply analysis. The company serves customers in banking and capital markets, chemicals and industrials, consumer products, energy and utilities, financial services, healthcare, insurance, life sciences, manufacturing, media, mining, metals and materials, oil and gas, real estate, retail, sports, telecommunications, and transportation industries. Its clients include domestic and foreign companies; federal, state, and local domestic government agencies; governments of foreign countries; public and private utilities; and national and international trade associations. CRA International, Inc. was founded in 1965 and is headquartered in Boston, Massachusetts.
Advisors' Opinion:- [By Lisa Levin]
CRA International (NASDAQ: CRAI) shares reached a new 52-week high of $26.845. CRA International shares have jumped 45.84% over the past 52 weeks, while the S&P 500 index has gained 18.08% in the same period.
Hot Stocks To Own Right Now: LSB Industries Inc (LXU)
LSB Industries, Inc., incorporated on January 21, 1977, is a diversified holding company involved in manufacturing and marketing operations through its subsidiaries. The Company together with its wholly owned subsidiaries owns Chemical Business and Climate Control Business. Chemical Business manufactures and sells nitrogen-based chemical products produced from four facilities located in El Dorado, Arkansas; Cherokee, Alabama; Pryor, Oklahoma, and Baytown, Texas for the agricultural, industrial, and mining markets. Climate Control Business manufactures and sells a range of heating, ventilation and air conditioning (HVAC) products in the niche markets the Company serves consisting of geothermal and water source heat pumps, hydronic fan coils, large custom air handlers, modular geothermal and other chillers and other related products used to control the environment in commercial/institutional and residential new building construction, renovation of existing buildings and replacement of existing systems. On October 31, 2012, Zena Energy LLC acquired working interests in certain natural gas properties located in Wyoming County, Pennsylvania, within the Marcellus Shale.
Chemical Business
The Company�� products in the Chemical Business include high purity and commercial grade anhydrous ammonia for industrial and agricultural applications, industrial and fertilizer grade ammonium nitrate (AN), urea ammonium nitrate (UAN), sulfuric acids, nitric acids in various concentrations, nitrogen solutions, diesel exhaust fluid (DEF) and various other products. The Company�� Chemical Business is a supplier to chemical and industrial companies. Its other products include anhydrous ammonia, ammonium nitrate ammonia solution for agricultural applications, blended and regular nitric acid, mixed nitrating acids, and industrial grade AN and solutions for the mining industry. The Company sells hese agricultural products to farmers, ranchers, fertilizer dealers and distributors primarily in the ran! ch land and grain production markets in the United States. The Company�� Chemical Business establishes long-term relationships with wholesale agricultural distributors and retailers and also sells directly to agricultural end-users through its network of wholesale and retail distribution centers. The Company�� Chemical Business manufactures and sells industrial acids and other chemical products primarily to the polyurethane, paper, fibers, fuel additives, emission control, and electronics industries. Its Chemical Business is also a niche market supplier of industrial and high purity ammonia for many specialty applications, including the reduction of air emissions from power plants.
Climate Control Business
The Company�� Climate Control Business manufactures and sells a range of standard and custom designed geothermal and water source heat pumps and hydronic fan coils, as well as custom air handlers and modular chiller systems, including modular geothermal chillers and simultaneous heating and cooling modules. These products are for use in commercial/institutional and residential HVAC systems. Its products are installed in some of the commercial/institutional developments in the United States, including the Prudential Tower, Rockefeller Plaza, Trump Tower, Time Warner Center and many others. In addition, it has presence in the lodging sector with installations in numerous Hyatt, Marriott, Four Seasons, Starwood, Ritz Carlton and Hilton hotels, among others. Its Climate Control Business manufactures and distributes its products from seven facilities located in Oklahoma City, Oklahoma. The Company also provides geothermal heat pumps in residential and commercial/institutional applications. Its products are sold to the commercial/institutional markets, as well as single and multi-family residential new construction, renovation and replacements. The Company is a provider of hydronic fan coils targeting commercial and institutional markets. It manufactures its products in many! sizes an! d configurations, as required by the purchaser, to fit the space and capacity requirements of hotels, motels, schools, hospitals, apartment buildings, office buildings and other commercial/institutional or residential structures. The Climate Control Business sells its products primarily to mechanical contractors, original equipment manufacturers (OEMs) and distributors. Its Climate Control Business market includes commercial/institutional and residential new building construction, renovation of existing buildings and replacement of existing systems.
The Company competes with Agrium, CF Industries, Coffeyville Resources, Dyno Nobel, Koch, Potash Corporation, Yara International, Carrier, Trane, Nortek, McQuay, and Bosch.
Advisors' Opinion:- [By James E. Brumley]
With a market cap of only $893 million, it's not like LSB Industries, Inc. (NYSE:LXU) is the kind of company that garners a ton of attention. On the other hand, over the past several months, LXU has garnered far more attention than it likely wanted. The turbulence seems to be mostly behind it, however, and though the stock is now overbought thanks to the proverbial clearing of the dust, for long-haul investors, LSB Industries may be worth a closer look.
No comments:
Post a Comment